Takafumi Akasu
Overview
Explore the profile of Takafumi Akasu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
101
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito Z, Koido S, Kato K, Odamaki T, Horiuchi S, Akasu T, et al.
Cancers (Basel)
. 2022 Nov;
14(21).
PMID: 36358797
Characteristic bile duct and gut microbiota have been identified in patients with chronic biliary tract disease. This study aimed to characterize the fecal and bile microbiota in biliary tract cancer...
2.
Chiba M, Kato M, Kinoshita Y, Akasu T, Matsui H, Shimamoto N, et al.
Gastrointest Endosc
. 2022 Nov;
97(4):722-731.e7.
PMID: 36343675
Background And Aims: The need for mastering standard imaging techniques for convex EUS in the biliopancreatic regions has been increasing; however, large variations in the aptitude for achieving EUS competency...
3.
Torisu Y, Chiba M, Kato M, Kinoshita Y, Akasu T, Kanai T, et al.
DEN Open
. 2022 Oct;
3(1):e166.
PMID: 36189168
Objectives: Selection criteria for self-expandable metal stents (SEMSs) with or without cover during palliative treatment of distal malignant biliary obstruction (DMBO) remain unclear. We evaluated factors associated with time to...
4.
Kanazawa K, Chiba M, Kato M, Kinoshita Y, Akasu T, Matsui H, et al.
Diagnostics (Basel)
. 2022 Aug;
12(8).
PMID: 36010332
Background: The utility of contrast-enhanced harmonic endoscopic ultrasonography (CH-EUS) alone in the biliopancreatic region appears to be limited because it is highly dependent on the experience and skill of the...
5.
Kinoshita A, Hagiwara N, Osawa A, Akasu T, Matsumoto Y, Ueda K, et al.
In Vivo
. 2022 Mar;
36(2):865-873.
PMID: 35241544
Background/aim: We aimed to investigate the association between The Geriatric Nutritional Risk Index (GNRI) and the tolerability of lenvatinib in patients with hepatocellular carcinoma (HCC). Patients And Methods: We retrospectively...
6.
Kinoshita A, Hagiwara N, Osawa A, Akasu T, Matsumoto Y, Ueda K, et al.
J Oncol Pharm Pract
. 2022 Feb;
29(3):626-636.
PMID: 35112972
Introduction: Management of elderly patients with cancer has become a global issue. We investigated the safety and tolerability of lenvatinib in hepatocellular carcinoma (HCC) patients ≥80 years old. Methods: We...
7.
Tomita Y, Torisu Y, Chiba M, Kinoshita Y, Akasu T, Shimamoto N, et al.
JGH Open
. 2021 Sep;
5(9):1092-1096.
PMID: 34584980
Background And Aim: Fine-needle biopsy (FNB) needles obtain more core samples and support the shift from cytologic to histologic evaluation; however, recent studies have proposed a superior diagnostic potential for...
8.
Kiryu S, Ito Z, Ishikawa M, Akasu T, Matsumoto Y, Hirooka S, et al.
J Med Case Rep
. 2020 Nov;
14(1):213.
PMID: 33158457
Introduction: Pericardial effusion is a rare complication of pancreatic cancer. We report a case of cardiac tamponade secondary to pancreatic cancer. Case Presentation: A 68-year-old Japanese man was diagnosed as...
9.
Yoshida S, Ito Z, Suka M, Bito T, Kan S, Akasu T, et al.
Cancer Invest
. 2019 Sep;
37(9):463-477.
PMID: 31490702
The associations of the immunological status of the pancreatic ductal adenocarcinoma (PDA) microenvironment with prognosis were assessed. A high tumor-infiltrating lymphocyte (TIL) density was associated with a better prognosis. Importantly,...
10.
Ito Z, Kan S, Bito T, Horiuchi S, Akasu T, Yoshida S, et al.
Oncology
. 2019 Jun;
97(3):135-148.
PMID: 31216557
Background: We have developed a Wilms' tumor 1 (WT1)-targeting dendritic cell (DC)-based cancer vaccine combined with standard chemotherapy for patients with advanced pancreatic ductal adenocarcinoma (PDA). Methods: We evaluated predictive...